Drug Trial Radar · NCT06544291
Combined THC and CBD for OUD and Chronic Pain
Last checked: Nov 20, 2026Latest source record: Jul 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
147
Planned (sponsor's estimate)
Start
Oct 22, 2024
Primary completion
Jan 28, 2028
Study completion Jan 28, 2028
Sponsor
- Lead sponsor
- Yale UniversityAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Institute on Drug Abuse (NIDA); National Institutes of Health (NIH)
- First posted
- Aug 9, 2024
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this phase 2 study is to investigate the therapeutic potential of orally administered combined delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) in relieving both pain and cue-induced opioid craving in people with co-occurring opioid use disorder (OUD) and chronic pain who are undergoing methadone therapy.
Conditions
- Chronic Pain
- Opioid Use Disorder
Interventions
CBD 300mgDrug
3 Nantheia™ (100mg) softgel capsules and 3 placebo (0mg) softgel capsules will be administered to participants on one of the three test session days.
CBD 600mgDrug
6 Nantheia™ (100mg) softgel capsules will be administered to participants on one of the three test session days.
Placebo 0mgDrug
6 placebo (0 mg) softgel capsules will be administered to participants on one of the three test session days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Outcome Variable #1: Pain SensitivityTime frame: Up to 8 hours
- Primary Outcome Variable #2: Opioid CravingTime frame: Baseline and +180 minutes post dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Connecticut Mental Health Center
New Haven, Connecticut · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.